About the Technical Support category
|
|
0
|
163
|
25 April 2021
|
Defined schema for v2g and variant-index data
|
|
2
|
7
|
5 August 2022
|
Discrepancy in variant reference allele from Open Targets and gnomAD
|
|
5
|
110
|
5 August 2022
|
Repeated records in OpenTargets Genetics PheWAS table report?
|
|
2
|
32
|
5 August 2022
|
Engage Mendelian Randomization to Open Targets platform
|
|
1
|
65
|
20 May 2022
|
Text mining evidence issue
|
|
3
|
57
|
22 April 2022
|
Is all linkage presented in the 'evidence' folder direct evidence?
|
|
3
|
192
|
23 March 2022
|
Documentation for reproducing platform target profiles from data downloads?
|
|
1
|
76
|
16 March 2022
|
Where to find the harmonic sum calculations in the code?
|
|
3
|
154
|
12 March 2022
|
Does target-disease evidence from clinical trials include control arm drugs?
|
|
3
|
117
|
21 January 2022
|
What is the backend database system that is used for open targets data?
|
|
1
|
142
|
9 December 2021
|
Possible Parquet data format problem with table "molecule" when trying to load with HAIL
|
|
1
|
123
|
2 November 2021
|
GraphQL Interface failing to fetch 'knownDrugs'
|
|
2
|
188
|
20 August 2021
|
Details on ChEMBL gene target links
|
|
4
|
139
|
9 August 2021
|
How to deploy a local instance of OpenTargets?
|
|
2
|
178
|
6 August 2021
|
Adding FDA data to Open Targets with Scala and Spark
|
|
0
|
175
|
6 May 2021
|
Re-writing the drug index
|
|
0
|
164
|
5 May 2021
|